ANI Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
44.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.55
|
0.64
|
0.09
|
16.36%
|
|
2022-06-30
|
0.22
|
0.13
|
-0.09
|
-40.91%
|
|
2022-03-31
|
0.09
|
-0.12
|
-0.21
|
-233.33%
|
|
2021-12-31
|
0.74
|
0.54
|
-0.20
|
-27.03%
|
|
2021-09-30
|
0.70
|
1.01
|
0.31
|
44.29%
|
|
2021-06-30
|
0.69
|
0.67
|
-0.02
|
-2.90%
|
|
2021-03-31
|
0.71
|
1.04
|
0.33
|
46.48%
|
|
2020-12-31
|
0.94
|
0.80
|
-0.14
|
-14.89%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.65
|
|
2021-12-31
|
3.26
|
|
2020-12-31
|
3.50
|
|
2019-12-31
|
5.05
|
|
2018-12-31
|
5.06
|
|
2017-12-31
|
3.91
|
|
2016-12-31
|
3.80
|
|
2015-12-31
|
2.44
|
|
2014-12-31
|
1.20
|
|
2013-12-31
|
-5.81
|
|
2012-12-31
|
-8.12
|
|
2011-12-31
|
-19.44
|
|
2010-12-31
|
-25.20
|
|
2009-12-31
|
-50.40
|
|
2008-12-31
|
-23.04
|
|
2007-12-31
|
-10.80
|
|
2006-12-31
|
4.68
|
|
2005-12-31
|
-18.00
|
|
2004-12-31
|
-25.35
|
|
2003-12-31
|
-19.64
|
|
2002-12-31
|
-19.66
|
|
2001-12-31
|
-5.97
|